Defining pediatric sepsis by different criteria: Discrepancies in populations and implications for clinical practice

Pediatric Critical Care Medicine

Volumn 13, Issue 4, 2012, Pages

  Weiss, Scott L ^a   Parker, Brandon ^b   Bullock, Maria E ^a   Swartz, Sheila ^d   Price, Carolynn ^d   Wainwright, Mark S ^c   Goodman, Denise M ^a  

^a Divisions of Critical Care   (United States)

^b Neurology   (United States)

^c Neurology   (United States)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Biomedical research; Clinical trials; Intensive care units; International Classification of Disease; pediatric; Sepsis; Septic shock

Indexed keywords

VASOACTIVE AGENT;

ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL RESEARCH; COHORT ANALYSIS; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; SCREENING; SEPTIC SHOCK; SYSTEMATIC ERROR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONSENSUS; FEMALE; HUMANS; MALE; OBSERVER VARIATION; SEPSIS; SHOCK, SEPTIC;

EID: 84864282573     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31823c98da     Document Type: Article

References (24)

1. Brilli RJ, Goldstein B: Pediatric sepsis definitions: Past, present, and future. Pediatr Crit Care Med 2005; 6: S6-S8 (Pubitemid 40724244)
2. Fischer JE: Physicians' ability to diagnose sepsis in newborns and critically ill children. Pediatr Crit Care Med 2005; 6: S120-S125
3. Goldstein B, Giroir B, Randolph A, et al: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2-8
4. Brierley J, Carcillo JA, Choong K, et al: Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009; 37: 666-688
5. Dellinger RP, Levy MM, CarletJM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327
6. Watson RS, Carcillo JA, Linde-Zwirble WT, et al: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167: 695-701 (Pubitemid 36801744)
7. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554 (Pubitemid 36437931)
8. Ollendorf DA, Fendrick AM, Massey K, et al: Is sepsis accurately coded on hospital bills? Value Health 2002; 5: 79-81 (Pubitemid 34274865)
9. Dougherty D, Conway PH: The "3T's" road map to transform US health care: The "how" of high-quality care. JAMA 2008; 299: 2319-2321 (Pubitemid 351724400)
10. Rothwell PM: External validity of randomised controlled trials: "To whom do the results of this trial apply?". Lancet2005; 365: 82-93 (Pubitemid 40082150)
11. Weiss S, Haymond S, Ralay-Ranaivo H, et al: Decreased plasma asymmetric dimethylarginine (ADMA) and altered arginine metabolism in pediatric sepsis. Crit Care Med 2010; 38: A61
12. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310 (Pubitemid 32641789)
13. Leteurtre S, Martinot A, Duhamel A, et al: Validation of the paediatric logistic organ dysfunction (PELOD) score: Prospective, observational, multicentre study. Lancet2003; 362: 192-197 (Pubitemid 36859934)
14. Gaies MG, Gurney JG, Yen AH, et al: Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 2010; 11: 234-238
15. Liddy C, Wiens M, Hogg W: Methods to achieve high interrater reliability in data collection from primary care medical records. Ann Fam Med 2011; 9: 57-62
16. Charlson ME, Horwitz RI: Applying results of randomised trials to clinical practice: Impact of losses before randomisation. BMJ 1984; 289: 1281-1284 (Pubitemid 15217616)
17. Maasland L, van Oostenbrugge RJ, Franke CF, et al: Patients enrolled in large randomized clinical trials of antiplatelettreatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: The Netherlands Stroke Survey. Stroke 2009; 40: 2662-2668
18. Stein BD, Charbeneau JT, Lee TA, et al: Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: How you count matters. COPD 2010; 7: 164-171
19. Sands KE, Bates DW, Lanken PN, et al: Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997; 278: 234-240 (Pubitemid 27339591)
20. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709 (Pubitemid 32204987)
21. Abraham E, Laterre PF, Garg R, et al: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005; 353: 1332-1341 (Pubitemid 41362701)
22. Tidswell M, Tillis W, Larosa SP, et al: Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit Care Med 2010; 38: 72-83
23. Wasserman RC: Electronic medical records (EMRs), epidemiology, and epistemology: Reflections on EMRs and future pediatric clinical research. Acad Pediatr 2011; 11: 280-287
24. Gilbert EH, Lowenstein SR, Koziol-McLain J, et al: Chart reviews in emergency medicine research: Where are the methods? Ann Emerg Med 1996; 27: 305-308 (Pubitemid 26085005)